Beruflich Dokumente
Kultur Dokumente
1080|www.pidj.com
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
RESULTS
Over a 2-year period, a convenience sample of 848 mother
infant pairs was enrolled (Fig. 1). Ten withdrew during the course
of the study. Because the remaining 838 infants included 9 sets
of twins, a total of 829 HIV-infected women were enrolled. The
nationality of 804 of these women was known and 43% were
foreign, 86% of whom were from Zimbabwe. The infants in this
cohort have been previously described.12 Briefly, 606 (72%) of the
838 enrolled infants accessed diagnostic testing at RMMCH and 85
(10%) underwent testing at other facilities (Fig. 1). An HIV status
was established for an additional 19 infants who defaulted from the
study by HIV testing of DBS samples collected for study purposes.
An HIV status was therefore available for 85% (710) of enrolled
infants. IU infection was excluded in the remaining 128 defaulting infants by virtue of negative birth DBS results, but no samples
were available to determine their HIV status at 6 weeks. In total, 38
HIV-infected infants were identified in the cohort, comprising 29
(76%) infants who tested positive at birth (IU infections) and 9 who
were negative at birth but positive by 6 weeks (IP infections) (Fig.
1). An additional 5 HIV-infected infants were later identified. Two
infants who were HIV-uninfected at 6 weeks of age later tested PCR
positive in the context of breast-feeding (postnatal transmission).
An additional 3 infants tested negative at birth, defaulted from the
study at 2 weeks of age and had positive PCR tests at 6 months or
older. Because it was unclear whether these infants were infected
IP or later as a result of breast-feeding, they were excluded from the
cohort of IP-infected infants.
All but 1 of the 838 enrolled infants (99.9%) received NVP
at birth (Fig. 2). Majority (92%) of these infants received sdNVP
according to the 2008 guidelines. Exclusive breast-feeding, only
recommended toward the end of the study,14 was reported in 89 (11%)
infants in the cohort. The 2 infants with postnatal transmissions
received sdNVP. Data regarding cotrimoxazole administration were
not collected. Of the 606 infants who accessed routine diagnostic
testing at RMMCH, 565 (93%) returned to receive their results
and 26 (4.3%) were HIV infected (Fig. 2). Of the infected infants
identified at RMMCH, 25 (96%) received PCR results and 23 (88%)
initiated ART. Two of the 3 infants who did not initiate treatment
were LTFU and 1 moved to his rural home before commencing
ART. The 23 infants who initiated ART were followed for a median
of 51.6 weeks (range 0.0112.1 weeks). Ten (43%) of these infants
were not in care at the end of the study because 7 infants, 2 of
whom had achieved viral suppression on treatment, were LTFU
and 3 infants died shortly after initiating ART. Of the 13 infants in
care, 12 were virologically suppressed and 1 was in the process of
achieving suppression. Retention in care of HIV-infected infants
was reasonable until the first clinic visit for care, but decreased
dramatically between ART initiation (88%) and achieving viral
suppression. In addition to the 26 HIV-infected infants who were
diagnosed at RMMCH, 4 infected infants defaulted from the study
and were diagnosed elsewhere (Fig. 2). One of these 4 infants died
in hospital at 4.0 weeks of age, 1 returned to RMMCH for treatment
at 20.1 months of age and was in care at the end of the study and the
outcomes of the remaining 2 infants are unknown. Therefore, of the
30 infants who accessed a diagnosis through the PMTCT program,
14 were in care at the end of the study, having been followed up
for a median of 67.7 weeks, and a total of 4 (13%) infants died. An
additional 8 infected infants defaulted from the study and did not
www.pidj.com|1081
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
Lilian et al
10 withdrew
606 infants
tested at RMMCH
85 infants
tested at other facilities
26 HIV+
580 HIV-
4 HIV+
78 HIV-
(18 IU + 8 IP)
at 6 weeks
(3 IU + 1 IP)
at 6 weeks
147 infants
did not test
3 HIV
status unknown
at 6 weeks *
8 HIV+
11 HIV-
(8 IU)
at 4-6 weeks
128 HIV
status unknown
at 6 weeks
HIV+, Human Immunodeficiency Virus positive; HIV-, Human Immunodeficiency Virus negative; IP, Intrapartum; IU, In Utero; RMMCH,
Rahima Moosa Mother and Child Hospital
HIV status established by testing available dried blood spot samples collected for study purposes.
Tested negative at birth, defaulted from the study at 2 weeks of age and only had positive PCR tests at 6 months or older.
Status at 6 weeks of age unknown, but no IU-infection as dried blood spot samples collected at birth tested negative.
FIGURE 2. PMTCT care cascade for HIV-exposed infants born at RMMCH. The 565 infants who attended the result visit represent only 67% of the total 838 infants in the cohort. Compared with the total number of perinatally infected infants (n = 38),
68% were diagnosed at RMMCH, 61% initiated treatment and 34% remained in care. Assuming the 2 HIV-infected infants
with unknown outcomes that were diagnosed at other facilities did access treatment and remained in care, then a maximum
42% of infected infants would have been in care at the end of the study. Of the 14 infants remaining in care, 12 of those diagnosed at RMMCH were virologically suppressed and the other 2 infants were in the process of achieving suppression.
1082|www.pidj.com
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
TABLE 1. Antenatal PMTCT Care and Maternal Characteristics by Method of Infant Diagnosis*
n
Mothers
Infants
HIV-infected infants
Age (yr)
Nationality: local
Antenatal clinic visit
20wk gestation
Accessed antenatal CD4
testing
Accessed any antenatal
PMTCT prophylaxis
Antenatal PMTCT from
28wk gestation
Peripartum viral load (log)
1. Mothers of Infants
Diagnosed at
RMMCH
2. Mothers of Infants
Diagnosed at Facilities Other
Than RMMCH
3. Mothers of Infants
Who Defaulted From the
PMTCT Program
602
606
26
28.3
(18.244.8; n = 602)
354/584
(60.6)
148/588
(25.2)
551/602
(91.5)
555/602
(92.2)
243/602
(40.4)
3.73
(0.005.72; n = 259)
82
85
4
27.4
(18.642.1; n = 82)
47/82
(57.3)
15/79
(19.0)
68/82
(82.9)
71/82
(86.6)
34/82
(41.5)
4.16
(0.005.48; n = 43)
145
147
8
26.5
(16.241.1; n = 145)
58/138
(42.0)
18/140
(12.9)
98/145
(67.6)
115/144
(79.9)
38/144
(26.4)
4.84
(4.385.59; n = 8)
0.002
<0.001
0.005
<0.001
<0.001
0.006
<0.001
*Data are n/total (%) for categorical variables and median (range; n) for continuous variables. The total number of mothers varies due to missing data.
Overall comparison of all 3 groups. All significant results in the overall comparison were significantly different between groups 1 and 3.
median age of 36.5 weeks; a median of 18.4 weeks lapsed from the
time treatment was initiated to virological suppression (Fig. 3).
results (Fig. 3). Delays occurred when infants were referred from the
diagnostic clinic to the treatment clinic, with a median time interval
of 2.1 weeks from the result visit to first presentation for care. Once
infants had presented to the treatment clinic, a median of 2.5 weeks
lapsed before ART was initiated. By 12 weeks of age, only 4 infants
had initiated ART. Two symptomatic infants who were admitted to
hospital were fast-tracked onto treatment at 6.3 and 8.6 weeks of age
and were in care at the end of the study. The other 2 infants initiated
treatment at 9.4 and 10.9 weeks of age but died shortly thereafter.
Virological suppression occurred in 14 (54%) infected infants at a
DISCUSSION
Eighty-two percent of HIV-exposed infants in this cohort
received an HIV status by virtue of routine testing at 6 weeks of
age. This EID coverage is equivalent to that reported for Gauteng
province, the region where RMMCH is located.18 It is therefore
likely that all HIV-infected and uninfected infants in the cohort
n
6.6
PCR test
26
10.6
25
ART initiation
12.6
23
Virological suppression
16.0
23
36.5
14
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
Age (weeks)
Time intervals (weeks): median (range)
PCR test to ART initiation: 10.1 (1.9 - 24.3)
PCR result visit to first visit for care: 2.1 (0.4 - 20.3)
PCR result visit to ART initiation: 6.1 (-3.3 - 20.3)
First visit for care to ART initiation: 2.5 (-7.9 - 12.0)
ART initiation to virological suppression: 18.4 (8.0 - 64.3)
ART, Antiretroviral Therapy; PCR, Polymerase Chain Reaction
FIGURE 3. Median age at PCR testing, receipt of results and treatment for HIV-infected infants identified at RMMCH.
2013 Lippincott Williams & Wilkins
www.pidj.com|1083
Lilian et al
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
1084|www.pidj.com
ACKNOWLEDGMENTS
The authors acknowledge the financial support provided by
UNICEF and the National Health Laboratory Service, Johannesburg, South Africa. The opinions expressed herein do not necessarily reflect those of the funders. The authors thank all infants and
their caregivers for participating in this study, the study team, in
particular Nkele Selepe and Mavis Zulu for their dedication and
Prof. Elena Libhaber for statistical guidance.
REFERENCES
1. Zijenah LS, Moulton LH, Iliff P, et al.; ZVITAMBO Study Group. Timing
of mother-to-child transmission of HIV-1 and infant mortality in the first 6
months of life in Harare, Zimbabwe. AIDS. 2004;18:273280.
2. Marston M, Becquet R, Zaba B, et al. Net survival of perinatally and postnatally HIV-infected children: a pooled analysis of individual data from subSaharan Africa. Int J Epidemiol. 2011;40:385396.
3. Bourne DE, Thompson M, Brody LL, et al. Emergence of a peak in early
infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23:101106.
4. The Joint United Nations Programme on HIV/AIDS (UNAIDS).
Global Report: UNAIDS Report on the Global AIDS Epidemic. Geneva:
UNAIDS; 2012.
5. Johnson LF. Access to antiretroviral treatment in South Africa, 2004 - 2011.
South Afr J HIV Med. 2012;13:2227.
The Pediatric Infectious Disease Journal Volume 32, Number 10, October 2013
www.pidj.com|1085